TEMAZEPAM - AN OVERVIEW

Stay away from coadministration with delicate CYP3A substrates. If coadministration unavoidable, check for adverse reactions and cut down CYP3A substrate dose in accordance with products labeling.In only one-night, double-blind, parallel-team demo comparing estazolam two mg and placebo in sufferers admitted for elective operation and necessitating